A native of the Bay Area, is a neuroscientist focused on drug discovery and development with expertise in cytoskeletal dynamics. In 2009 she joined Scripps Research and established a research program focused on developing neurotherapeutics. Dr. Miller’s laboratory made the initial discovery of nonmuscle myosin II’s (NMII) therapeutic potential and was recognized for these efforts with a Presidential Early Career Award for Scientists and Engineers (PECASE), presented by President Obama in 2016. To advance the therapeutic potential of molecular motors like NMII, Dr. Miller launched a collaborative medication development program with Dr. Griffin and Kamenecka. In addition to Dr. Miller’s scientific expertise, she has training in venture capital and was named a Kauffman Finalist in Venture Investment.